LEGISLATIVE FISCAL OFFICE
Fiscal Note
Fiscal Note On: HB 899 HLS 24RS 2081
Bill Text Version: ENROLLED
Opp. Chamb. Action:
Proposed Amd.:
Sub. Bill For.:
Date: May 31, 2024 8:42 PM Author: WRIGHT
Dept./Agy.: LDH
Subject: Patients law Analyst: Shawn Hotstream
HEALTH/MEDICAL TREATMENT EN NO IMPACT See Note Page 1 of 1
Provides relative to the Hope for Louisiana Patients Law
Proposed law authorizes a manufacturer operating within an eligible facility (in accordance with all applicable Federalwide Assurance for
the Protection of Human Subjects laws) to make available an individualized investigative treatment, and a patient may request an
individualized investigational drug, biological product, or device from an eligible facility or manufacturer operating within an eligible facility.
Proposed law provides an eligible facility or manufacturer may provide the drug or biological product to an eligible patient without
receiving compensation, or may require the patient to pay the cost of such treatment. This measure does require a health insurance
issuer to expand coverage or a state agency or any governmental agency to pay costs associated with the use or treatment of a patient,
however, a health plan, third party administrator, or governmental agency may provide coverage for the cost of an individualized
investigational drug, product or device. Proposed law limits liability, and prevents a licensing board from revoking or suspending a
healthcare provider’s license based on the provider’s recommendation to a patient to have access to this care. Proposed law provides for a
prohibition of private causes of action and insurance mandates.
EXPENDITURES 2024-25 2025-26 2026-27 2027-28 2028-29 5 -YEAR TOTAL
State Gen. Fd. $0 $0 $0 $0 $0 $0
Agy. Self-Gen. $0 $0 $0 $0 $0 $0
Ded./Other $0 $0 $0 $0 $0 $0
Federal Funds $0 $0 $0 $0 $0 $0
Local Funds $0 $0 $0 $0 $0 $0
Annual Total $0 $0 $0 $0 $0 $0
REVENUES 2024-25 2025-26 2026-27 2027-28 2028-29 5 -YEAR TOTAL
State Gen. Fd. $0 $0 $0 $0 $0 $0
Agy. Self-Gen. $0 $0 $0 $0 $0 $0
Ded./Other $0 $0 $0 $0 $0 $0
Federal Funds $0 $0 $0 $0 $0 $0
Local Funds $0 $0 $0 $0 $0 $0
Annual Total $0 $0 $0 $0 $0 $0
EXPENDITURE EXPLANATION
There is no anticipated direct material effect on expenditures in the Louisiana Department of Health or the Office of Group Benefits as a
result of this measure. The Hope for Louisiana Patients Law authorizes patient access to individualized investigational drugs, products, or
devices. This measure does not contain a requirement for insurers to provide coverage for such drugs, products, or devices, but states
that health plans, third party administrators, and governmental agencies may provide such coverage. OGB’s self-funded health plan
specifically excludes coverage for investigational or experimental treatments/procedures and drugs regardless of medical necessity, and
anticipates no change in pharmacy claim expenditures under this measure.
REVENUE EXPLANATION
There is no anticipated direct material effect on governmental revenues as a result of this measure.
Senate Dual Referral Rules House
13.5.1 >= $100,000 Annual Fiscal Cost {S & H} 6.8(F)(1) >= $100,000 SGF Fiscal Cost {H & S}
Patrice Thomas
13.5.2 >= $500,000 Annual Tax or Fee 6.8(G) >= $500,000 Tax or Fee Increase
Change {S & H} or a Net Fee Decrease {S} Deputy Fiscal Officer